At the Cancer Genomics and Therapeutics Laboratory (CGTL), our mission is to advance the understanding of cancer at the genomic level and develop novel therapeutic strategies to improve patient outcomes. We combine cutting-edge genomic technologies with computational approaches to identify molecular mechanisms underlying cancer initiation, progression, and treatment resistance.
We believe in a highly collaborative and interdisciplinary approach to cancer research. Our laboratory brings together researchers with expertise in molecular biology, genetics, computational biology, and clinical oncology. We work closely with clinical partners to ensure our research addresses the most pressing challenges in cancer treatment and has a clear path to clinical translation.